All Articles

Circulating tumor DNA (ctDNA) in early-stage NSCLC: a new frontier in precision oncology

Functional significance of miR-218 in lung cancer

Censor-aware semi-supervised survival time prediction in lung cancer using clinical and radiomics features

Combining multiple approaches and omics technologies to detect circulating tumor cells (CTCs): a real clinical application in patients with early-stage non-small-cell lung cancer (NSCLC)?

Obatoclax enhances TRAIL-induced apoptosis in non-small-cell-lung-cancer cells by increasing TRAIL receptor expression, priming for mitochondrial apoptosis and reducing XIAP levels

Serum TUBB is a potential biomarker for the diagnosis of non-small cell lung cancer

Knockdown of the EEF1A2 gene reduces lung cancer brain metastasis by downregulating the BCL10/NFκB pathway

ImmuneScore as a novel RNA-based prognostic signature superior to PD-L1 in advanced non-squamous NSCLC patients receiving chemotherapy combined with immune checkpoint inhibitor therapy

Editorial on “Chinese expert consensus on the clinical practice of non-small cell lung cancer fusion gene detection based on RNA-based NGS” (2023 edition)

ZNF148/PFKP/PD-L1 axis promotes non-small cell lung cancer proliferation, migration and glycolysis

Application of radiomics and artificial intelligence in lung cancer immunotherapy: a guide and hurdles from clinical trials

Tumors due to chronic exposure to benzene and biomarkers of exposure

First molecular cytogenetic characterisation of tracheal squamous cell carcinoma cell line KLN 205

Mortality from COVID-19 in patients with lung cancer

Role of ¹⁸F-FDG PET/CT in detection of hematogenous metastases of advanced differentiated thyroid carcinoma: a systematic review and meta-analysis

Management of lung cancer in the COVID-19 pandemic: a review

Lung cancer management during the COVID-19 pandemic: experience of a medical oncology unit at a tertiary hospital in Singapore

Current updates in management of relapsed/refractory small cell lung cancer